However, angiogenesis inhibitors targeting the VEGF pathway have recently demonstrated antitumor effect in glioblastoma model but concomitantly select for resistant cells that yield tumor invasiveness and metastasis, due to activation of HIF-1 pathway [37], [38]. The gene discussed is HIF1A; the disease is glioblastoma.